首页 > 最新文献

Dermatologic Therapy最新文献

英文 中文
The Effect of an Er:YAG Laser Combined with a 755 nm Picosecond Laser on Tattoo Removal in a Rat Model Er:YAG 激光器与 755 nm 皮秒激光器结合使用对大鼠模型去除纹身的影响
IF 3.6 4区 医学 Q1 DERMATOLOGY Pub Date : 2024-02-21 DOI: 10.1155/2024/4509910
Tianyu E., Chen Bi, Xiaopeng Liu, Li Lin, Yongqian Cao

Laser tattoo removal is an effective technique, but multiple rounds of treatment are required to eliminate tattoos, which can be a challenge for patients who do not have the time. Additionally, there is relatively limited research on the mechanisms of laser tattoo removal, necessitating further in-depth studies. This study aimed to investigate the efficacy of an Er:YAG laser combined with a 755-picosecond laser for tattoo removal and the changes in skin diffuse reflection, pigment particle size, macrophage recruitment, and inflammatory factor levels during combined laser treatment. Our experiments used three sets of lasers—an Er:YAG laser, a 755 nm picosecond laser, and an Er:YAG laser combined with a 755 nm picosecond laser—for tattoo removal. The effects of tattoo removal at different time points were evaluated. Moreover, the mechanisms were explored using HE staining, immunohistochemistry, diffuse reflectance measurements, in vitro gel tests, mass spectrometry, and ELISA experiments. The combined treatment was more effective for tattoo removal in rats. The combined laser treatment effectively reduced diffuse reflection from the skin, thereby increasing the effective laser power, reducing the size of the pigment particles, allowing for easier removal of the pigment, and increasing the recruitment of dermal macrophages and the release of inflammatory factors, thus increasing the rate of tattoo removal in vivo.

激光洗纹身是一种有效的技术,但需要多轮治疗才能消除纹身,这对于没有时间的患者来说是一项挑战。此外,关于激光洗纹身机制的研究相对有限,因此有必要进一步深入研究。本研究旨在探讨 Er:YAG 激光与 755 皮秒激光联合用于去除纹身的疗效,以及联合激光治疗过程中皮肤漫反射、色素颗粒大小、巨噬细胞募集和炎症因子水平的变化。我们的实验使用了三组激光器--Er:YAG 激光器、755 nm 皮秒激光器和 Er:YAG 激光器与 755 nm 皮秒激光器的组合--来去除纹身。对不同时间点的去纹效果进行了评估。此外,还使用 HE 染色法、免疫组织化学法、漫反射测量法、体外凝胶试验、质谱法和 ELISA 实验等方法探讨了其作用机制。联合治疗对去除大鼠纹身更有效。联合激光治疗能有效减少皮肤的漫反射,从而提高激光的有效功率,减小色素颗粒的大小,使色素更容易去除,并增加真皮巨噬细胞的募集和炎症因子的释放,从而提高体内纹身的去除率。
{"title":"The Effect of an Er:YAG Laser Combined with a 755 nm Picosecond Laser on Tattoo Removal in a Rat Model","authors":"Tianyu E.,&nbsp;Chen Bi,&nbsp;Xiaopeng Liu,&nbsp;Li Lin,&nbsp;Yongqian Cao","doi":"10.1155/2024/4509910","DOIUrl":"10.1155/2024/4509910","url":null,"abstract":"<p>Laser tattoo removal is an effective technique, but multiple rounds of treatment are required to eliminate tattoos, which can be a challenge for patients who do not have the time. Additionally, there is relatively limited research on the mechanisms of laser tattoo removal, necessitating further in-depth studies. This study aimed to investigate the efficacy of an Er:YAG laser combined with a 755-picosecond laser for tattoo removal and the changes in skin diffuse reflection, pigment particle size, macrophage recruitment, and inflammatory factor levels during combined laser treatment. Our experiments used three sets of lasers—an Er:YAG laser, a 755 nm picosecond laser, and an Er:YAG laser combined with a 755 nm picosecond laser—for tattoo removal. The effects of tattoo removal at different time points were evaluated. Moreover, the mechanisms were explored using HE staining, immunohistochemistry, diffuse reflectance measurements, in vitro gel tests, mass spectrometry, and ELISA experiments. The combined treatment was more effective for tattoo removal in rats. The combined laser treatment effectively reduced diffuse reflection from the skin, thereby increasing the effective laser power, reducing the size of the pigment particles, allowing for easier removal of the pigment, and increasing the recruitment of dermal macrophages and the release of inflammatory factors, thus increasing the rate of tattoo removal in vivo.</p>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2024 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140444036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics of Basal Cell Carcinomas of the Scrotum: An Institutional Retrospective Review 阴囊基底细胞癌的临床特征:机构回顾性研究
IF 3.6 4区 医学 Q1 DERMATOLOGY Pub Date : 2024-01-19 DOI: 10.1155/2024/8871278
Qiuyan Duan, Yangfeng Lou, Longfei Yang, Peng Zhou

Objective. To analyse the clinical and pathologic features, discuss therapeutic strategies, and possibly cause and identify prognostic factors of scrotal basal cell carcinoma (BCC) in Chinese patients. Materials and Methods. Between January 2012 and December 2022, 12 patients with scrotal BCC were diagnosed and treated at our institution. A review was conducted based on the clinical characteristics, pathology slides, and tissues of these patients. Results. The median patient age was 69.26 ± 11.23 years. The skin lesions presented as red papules, blue-grey polypoid nodules, erythematous patches, brownish plaques, and so on. All patients were treated using wide excision, but the margins varied from 0.5 cm to 2 cm. HPV infection was checked in all lesions, with 4 out of 12 testing positive for P16 and 1 for HPV16 DNA. We found mottled positive expression of P16 in the cytoplasm and membrane. One patient developed left inguinal lymph node metastasis and was successfully treated using bilateral inguinal lymphadenectomy. The rest recovered well without relapse. Conclusions. BCC of the scrotum is rare, but long-term surveillance is recommended for BCC patients, and whether genital HPV infection is a noteworthy feature for these patients remains under investigation.

目的分析阴囊基底细胞癌(BCC)在中国患者中的临床和病理特征,探讨治疗策略,以及可能的病因和预后因素。材料与方法。2012年1月至2022年12月期间,我院诊断并治疗了12例阴囊基底细胞癌患者。根据这些患者的临床特征、病理切片和组织进行了回顾性分析。结果显示患者年龄中位数为(69.26 ± 11.23)岁。皮损表现为红色丘疹、蓝灰色息肉样结节、红斑、褐色斑块等。所有患者都接受了广泛切除术,但切除边缘从 0.5 厘米到 2 厘米不等。对所有病灶进行了人乳头瘤病毒感染检查,12 例中有 4 例检测出 P16 阳性,1 例检测出 HPV16 DNA 阳性。我们发现 P16 在细胞质和细胞膜上呈斑点状阳性表达。一名患者出现左侧腹股沟淋巴结转移,通过双侧腹股沟淋巴结切除术成功治愈。其余患者恢复良好,没有复发。结论。阴囊 BCC 很少见,但建议对 BCC 患者进行长期监测,生殖器 HPV 感染是否是这些患者的一个值得注意的特征仍在研究中。
{"title":"Clinical Characteristics of Basal Cell Carcinomas of the Scrotum: An Institutional Retrospective Review","authors":"Qiuyan Duan,&nbsp;Yangfeng Lou,&nbsp;Longfei Yang,&nbsp;Peng Zhou","doi":"10.1155/2024/8871278","DOIUrl":"10.1155/2024/8871278","url":null,"abstract":"<p><i>Objective</i>. To analyse the clinical and pathologic features, discuss therapeutic strategies, and possibly cause and identify prognostic factors of scrotal basal cell carcinoma (BCC) in Chinese patients. <i>Materials and Methods</i>. Between January 2012 and December 2022, 12 patients with scrotal BCC were diagnosed and treated at our institution. A review was conducted based on the clinical characteristics, pathology slides, and tissues of these patients. <i>Results</i>. The median patient age was 69.26 ± 11.23 years. The skin lesions presented as red papules, blue-grey polypoid nodules, erythematous patches, brownish plaques, and so on. All patients were treated using wide excision, but the margins varied from 0.5 cm to 2 cm. HPV infection was checked in all lesions, with 4 out of 12 testing positive for P16 and 1 for HPV16 DNA. We found mottled positive expression of P16 in the cytoplasm and membrane. One patient developed left inguinal lymph node metastasis and was successfully treated using bilateral inguinal lymphadenectomy. The rest recovered well without relapse. <i>Conclusions</i>. BCC of the scrotum is rare, but long-term surveillance is recommended for BCC patients, and whether genital HPV infection is a noteworthy feature for these patients remains under investigation.</p>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2024 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139613021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Characteristics, Treatment, and Prognosis of Amoxicillin-Induced AGEP/ALEP 阿莫西林诱发的 AGEP/ALEP 的临床特征、治疗和预后
IF 3.6 4区 医学 Q1 DERMATOLOGY Pub Date : 2024-01-13 DOI: 10.1155/2024/3885057
Haibo Lei, Zhiqiang Fan, Yang He, Wei Sun, Zuojun Li, Chunjiang Wang

Background. Amoxicillin was associated with acute generalized exanthematous pustulosis (AGEP), and the clinical characteristics were not clear. The purpose of this study was to explore the clinical characteristics of amoxicillin-induced AGEP and to provide a basis for prevention and treatment. Methods. Case reports and case series of amoxicillin-induced AGEP were collected for retrospective analysis by searching the Chinese and English databases from inception to January 31, 2023. Results. A total of 46 patients were included with a median age of 40 years (range 1.4, 87). The onset time of AGEP ranged from 6 hours to 28 days, with a median of 2.5 days. Fever occurred in 32 patients (69.6%), and pruritus occurred in 13 patients (28.3%). Ten patients (21.7%) had mucous membrane involvement and systemic involvement, respectively. Twenty-two patients had elevated neutrophils, with a median of 12850/mm3 (range 7880, 29140). Skin biopsy mainly showed subcorneal pustules (22 cases, 47.8%), spongy pustules (14 cases, 30.4%), and inflammatory cell infiltration (26 cases, 56.5%). Skin lesions disappeared in a median of 10 days (range 2, 42) after discontinuation of amoxicillin and administration of topical steroids (26 cases, 56.5%) as well as systemic corticosteroids (13 cases, 28.3%). Conclusions. AGEP is a rare complication of amoxicillin and is self-limiting. Clinicians should correctly identify AGEP and should avoid represcribing amoxicillin. Clinicians should correctly identify AGEP and avoid represcribing amoxicillin, which can prevent unnecessary treatment measures.

背景。阿莫西林与急性全身泛发性脓疱病(AGEP)有关,其临床特征尚不明确。本研究旨在探讨阿莫西林诱发 AGEP 的临床特征,为预防和治疗提供依据。研究方法通过检索从开始至2023年1月31日的中英文数据库,收集阿莫西林诱发AGEP的病例报告和系列病例进行回顾性分析。结果。共纳入 46 例患者,中位年龄为 40 岁(1.4-87 岁)。AGEP 的发病时间从 6 小时到 28 天不等,中位数为 2.5 天。32名患者(69.6%)出现发热,13名患者(28.3%)出现瘙痒。10名患者(21.7%)分别出现粘膜受累和全身受累。22名患者的中性粒细胞升高,中位数为12850/mm3(范围7880-29140)。皮肤活检主要显示角膜下脓疱(22 例,47.8%)、海绵状脓疱(14 例,30.4%)和炎性细胞浸润(26 例,56.5%)。停用阿莫西林、局部使用类固醇激素(26 例,56.5%)和全身使用皮质类固醇激素(13 例,28.3%)后,皮损在中位数 10 天(2-42 天)内消失。结论AGEP是阿莫西林的一种罕见并发症,具有自限性。临床医生应正确识别 AGEP,避免重新处方阿莫西林。临床医生应正确识别AGEP,避免重新处方阿莫西林,这样可以避免不必要的治疗措施。
{"title":"Clinical Characteristics, Treatment, and Prognosis of Amoxicillin-Induced AGEP/ALEP","authors":"Haibo Lei,&nbsp;Zhiqiang Fan,&nbsp;Yang He,&nbsp;Wei Sun,&nbsp;Zuojun Li,&nbsp;Chunjiang Wang","doi":"10.1155/2024/3885057","DOIUrl":"10.1155/2024/3885057","url":null,"abstract":"<p><i>Background</i>. Amoxicillin was associated with acute generalized exanthematous pustulosis (AGEP), and the clinical characteristics were not clear. The purpose of this study was to explore the clinical characteristics of amoxicillin-induced AGEP and to provide a basis for prevention and treatment. <i>Methods</i>. Case reports and case series of amoxicillin-induced AGEP were collected for retrospective analysis by searching the Chinese and English databases from inception to January 31, 2023. <i>Results</i>. A total of 46 patients were included with a median age of 40 years (range 1.4, 87). The onset time of AGEP ranged from 6 hours to 28 days, with a median of 2.5 days. Fever occurred in 32 patients (69.6%), and pruritus occurred in 13 patients (28.3%). Ten patients (21.7%) had mucous membrane involvement and systemic involvement, respectively. Twenty-two patients had elevated neutrophils, with a median of 12850/mm<sup>3</sup> (range 7880, 29140). Skin biopsy mainly showed subcorneal pustules (22 cases, 47.8%), spongy pustules (14 cases, 30.4%), and inflammatory cell infiltration (26 cases, 56.5%). Skin lesions disappeared in a median of 10 days (range 2, 42) after discontinuation of amoxicillin and administration of topical steroids (26 cases, 56.5%) as well as systemic corticosteroids (13 cases, 28.3%). <i>Conclusions</i>. AGEP is a rare complication of amoxicillin and is self-limiting. Clinicians should correctly identify AGEP and should avoid represcribing amoxicillin. Clinicians should correctly identify AGEP and avoid represcribing amoxicillin, which can prevent unnecessary treatment measures.</p>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2024 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139531048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tofacitinib for the Treatment of Refractory Progressive Vitiligo: A Retrospective Case Series 托法替尼治疗难治性进展期白癜风:回顾性病例系列
IF 3.6 4区 医学 Q1 DERMATOLOGY Pub Date : 2024-01-11 DOI: 10.1155/2024/9944826
Xiu-kun Sun, An-qi Sheng, Ai-e Xu

Treatment of progressive vitiligo aims to halt the spread of the disease and facilitate repigmentation of lesions. JAK inhibitor has been shown some therapeutic effects on vitiligo, but the data for the progressive vitiligo are limited. This retrospective study was performed to evaluate the efficacy and safety of oral tofacitinib in 25 refractory progressive vitiligo patients who experienced failure to previous steroid treatments. 16 (64%) of the 25 patients noted stopping disease progression, and nearly half of the 16 cases halted progression within one month. 10 (40%) patients had repigmentation in varying degrees. Combination with phototherapy was a key factor affecting the rate of repigmentation. Oral tofacitinib might be a potentially effective treatment for intractable progressive vitiligo. The limitations of the study include the retrospective, single-centre study with small sample size and lack of comparison with other systemic therapies.

治疗进展期白癜风的目的是阻止疾病的扩散,促进皮损的再着色。JAK抑制剂对白癜风有一定的治疗效果,但用于进展期白癜风的数据有限。这项回顾性研究旨在评估口服托法替尼治疗25例难治性进展期白癜风患者的疗效和安全性。25名患者中有16人(64%)的病情停止了进展,其中近一半患者的病情在一个月内停止了进展。10名患者(40%)出现了不同程度的色素沉着。与光疗相结合是影响色素沉着率的关键因素。口服托法替尼可能是治疗顽固性进展期白癜风的一种有效方法。这项研究的局限性包括:它是一项回顾性的单中心研究,样本量较小,而且没有与其他系统疗法进行比较。
{"title":"Tofacitinib for the Treatment of Refractory Progressive Vitiligo: A Retrospective Case Series","authors":"Xiu-kun Sun,&nbsp;An-qi Sheng,&nbsp;Ai-e Xu","doi":"10.1155/2024/9944826","DOIUrl":"10.1155/2024/9944826","url":null,"abstract":"<p>Treatment of progressive vitiligo aims to halt the spread of the disease and facilitate repigmentation of lesions. JAK inhibitor has been shown some therapeutic effects on vitiligo, but the data for the progressive vitiligo are limited. This retrospective study was performed to evaluate the efficacy and safety of oral tofacitinib in 25 refractory progressive vitiligo patients who experienced failure to previous steroid treatments. 16 (64%) of the 25 patients noted stopping disease progression, and nearly half of the 16 cases halted progression within one month. 10 (40%) patients had repigmentation in varying degrees. Combination with phototherapy was a key factor affecting the rate of repigmentation. Oral tofacitinib might be a potentially effective treatment for intractable progressive vitiligo. The limitations of the study include the retrospective, single-centre study with small sample size and lack of comparison with other systemic therapies.</p>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2024 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-01-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139438632","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relationship between Eating Styles and the Severity of Psoriasis: A Cross-Sectional Study in Thailand 饮食方式与银屑病严重程度之间的关系:泰国横断面研究
IF 3.6 4区 医学 Q1 DERMATOLOGY Pub Date : 2024-01-09 DOI: 10.1155/2024/6677244
Wanjarus Roongpisuthipong, Theerawut Klangjareonchai

Background. Psoriasis, a persistent inflammatory condition, is linked to several concurrent health issues. Among these, obesity stands out as a significant contributing factor, significantly influencing the development and seriousness of psoriasis. Furthermore, behavioral elements such as eating styles could potentially contribute to the activity of the disease. Objective. To investigate the relationships between eating styles and the clinical severity of psoriasis. Materials and Methods. A cross-sectional study among 158 chronic plaque psoriasis patients was conducted. Sociodemographic data and clinical presentation of psoriasis including risk factors and treatment, eating, stress, and sleep data were obtained from questionnaires. Psoriasis disease severity, weight, and height measurements, including bioelectrical impedance analysis were assessed. A multivariate logistic regression analysis was employed to assess eating patterns and identify notable factors linked to the severity of the disease. Results. After adjusting for the potential confounder, the emotional eating style was significantly associated with an increase in risk of psoriasis severity when compared to the restrained eating style (odds ratio, 3.9; 95% confidence interval, 1.52–9.81). Body mass index, body fat mass, eating attitude, alcohol consumption, nail involvement, psoriasis treatment, smoking status, duration of sleep, and stress status were not significant risk factors for disease severity. Conclusions. There is a significant correlation between emotional eating style and the severity of chronic plaque-type psoriasis in Asian patients. Further exploration into utilizing cognitive-behavioral therapy to address emotional eating styles as part of psoriasis management is warranted.

背景。银屑病是一种顽固性炎症,与多种并发健康问题有关。其中,肥胖是一个重要的诱发因素,对银屑病的发展和严重程度有重大影响。此外,饮食方式等行为因素也可能导致疾病的活动。研究目的研究饮食方式与银屑病临床严重程度之间的关系。材料与方法。对 158 名慢性斑块状银屑病患者进行横断面研究。通过问卷调查获得了社会人口学数据、银屑病临床表现(包括风险因素和治疗)、饮食、压力和睡眠数据。还评估了银屑病的严重程度、体重和身高测量值,包括生物电阻抗分析。采用多变量逻辑回归分析评估饮食模式,并找出与疾病严重程度相关的显著因素。结果显示在调整了潜在的混杂因素后,与节制饮食方式相比,情绪化饮食方式与银屑病严重程度风险的增加有显著相关性(几率比为 3.9;95% 置信区间为 1.52-9.81)。体重指数、体脂量、饮食态度、饮酒量、指甲参与程度、银屑病治疗情况、吸烟情况、睡眠时间和压力状况都不是银屑病严重程度的重要风险因素。结论亚洲患者的情绪化饮食方式与慢性斑块型银屑病的严重程度之间存在明显的相关性。有必要进一步探讨如何利用认知行为疗法来解决情绪化饮食方式问题,并将其作为银屑病治疗的一部分。
{"title":"The Relationship between Eating Styles and the Severity of Psoriasis: A Cross-Sectional Study in Thailand","authors":"Wanjarus Roongpisuthipong,&nbsp;Theerawut Klangjareonchai","doi":"10.1155/2024/6677244","DOIUrl":"10.1155/2024/6677244","url":null,"abstract":"<p><i>Background</i>. Psoriasis, a persistent inflammatory condition, is linked to several concurrent health issues. Among these, obesity stands out as a significant contributing factor, significantly influencing the development and seriousness of psoriasis. Furthermore, behavioral elements such as eating styles could potentially contribute to the activity of the disease. <i>Objective</i>. To investigate the relationships between eating styles and the clinical severity of psoriasis. <i>Materials and Methods</i>. A cross-sectional study among 158 chronic plaque psoriasis patients was conducted. Sociodemographic data and clinical presentation of psoriasis including risk factors and treatment, eating, stress, and sleep data were obtained from questionnaires. Psoriasis disease severity, weight, and height measurements, including bioelectrical impedance analysis were assessed. A multivariate logistic regression analysis was employed to assess eating patterns and identify notable factors linked to the severity of the disease. <i>Results</i>. After adjusting for the potential confounder, the emotional eating style was significantly associated with an increase in risk of psoriasis severity when compared to the restrained eating style (odds ratio, 3.9; 95% confidence interval, 1.52–9.81). Body mass index, body fat mass, eating attitude, alcohol consumption, nail involvement, psoriasis treatment, smoking status, duration of sleep, and stress status were not significant risk factors for disease severity. <i>Conclusions</i>. There is a significant correlation between emotional eating style and the severity of chronic plaque-type psoriasis in Asian patients. Further exploration into utilizing cognitive-behavioral therapy to address emotional eating styles as part of psoriasis management is warranted.</p>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2024 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139443871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata 托法替尼治疗小儿难治性脱发患者
IF 3.6 4区 医学 Q1 DERMATOLOGY Pub Date : 2024-01-05 DOI: 10.1155/2024/8336879
Eda Öksüm Solak, Murat Borlu

Alopecia areata (AA) significantly impacts mental health and quality of life in children. While current treatments often offer limited efficacy, noticeable remission occurs in responsive cases. Recent advancements in understanding AA’s pathogenesis have sparked hope for Janus kinase (JAK) inhibitors as potential treatments. However, studies on this promising avenue remain limited. Our retrospective evaluation of pediatric patients treated with systemic tofacitinib for alopecia showed significant improvements, notably at the 12-month mark, with only one patient experiencing an upper respiratory infection as a side effect. Nevertheless, our study’s retrospective design and small patient cohort highlight limitations. Larger randomized studies are crucial to comprehensively explore the efficacy and potential of JAK inhibitors in pediatric AA treatment.

斑秃(AA)严重影响儿童的心理健康和生活质量。虽然目前的治疗方法通常疗效有限,但在有反应的病例中会出现明显缓解。最近在了解 AA 发病机制方面取得的进展为 Janus 激酶(JAK)抑制剂作为潜在治疗方法带来了希望。然而,有关这一前景广阔的途径的研究仍然有限。我们对使用托法替尼治疗脱发的儿科患者进行了回顾性评估,结果显示患者的病情明显好转,尤其是在治疗12个月后,只有一名患者出现了上呼吸道感染的副作用。尽管如此,我们这项研究的回顾性设计和小规模患者群凸显了其局限性。更大规模的随机研究对于全面探索JAK抑制剂在儿科AA治疗中的疗效和潜力至关重要。
{"title":"Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata","authors":"Eda Öksüm Solak,&nbsp;Murat Borlu","doi":"10.1155/2024/8336879","DOIUrl":"10.1155/2024/8336879","url":null,"abstract":"<p>Alopecia areata (AA) significantly impacts mental health and quality of life in children. While current treatments often offer limited efficacy, noticeable remission occurs in responsive cases. Recent advancements in understanding AA’s pathogenesis have sparked hope for Janus kinase (JAK) inhibitors as potential treatments. However, studies on this promising avenue remain limited. Our retrospective evaluation of pediatric patients treated with systemic tofacitinib for alopecia showed significant improvements, notably at the 12-month mark, with only one patient experiencing an upper respiratory infection as a side effect. Nevertheless, our study’s retrospective design and small patient cohort highlight limitations. Larger randomized studies are crucial to comprehensively explore the efficacy and potential of JAK inhibitors in pediatric AA treatment.</p>","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"2024 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139383284","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Characteristics of COVID-19 Symptoms and Skin Manifestations among Nonhospitalized COVID-19 Patients with Psoriasis during the Omicron Pandemic in China: A Single-Center Survey-Based Study 中国Omicron大流行期间非住院COVID-19银屑病患者的COVID-19症状和皮肤表现特征:基于单中心调查的研究
IF 3.6 4区 医学 Q1 DERMATOLOGY Pub Date : 2023-12-26 DOI: 10.1155/2023/1559937
Yue Xiao, Xiwen Zhang, Xun Feng, Jingya Gao, Furong Li, Wenyao Mi, Mingqi Wang, Yuanxia Gu, Yiyi Wang, Wen Wang, W. Li
Background. The global impact of coronavirus 2019 (COVID-19) has raised concerns about the management of psoriasis patients, especially among those using biologics. Methods. We conducted a survey-based research among Omicron-infected (confirmed, probable, and suspected ones) psoriasis patients in the department of dermatology, West China Hospital, Sichuan University, from January 9th to January 22nd, 2023. We collected demographic and clinical information (psoriasis- and COVID-19-related) and conducted statistics analysis. Results. Of the 240 patients enrolled, they were classified by the psoriatic treatment, as biologics (n = 138), nonbiological systematic treatment (n = 52), and topical treatment or without pharmacological treatment (n = 50). This study showed the characteristics of Omicron-related symptoms and cutaneous signs in patients. We observed that patients who received topical treatment or without pharmacological treatment had a lower risk of presenting with COVID-19 symptoms in the fully adjusted logistic model (OR = 0.40, 95% CI: 0.18–0.90, and P=0.025). Moreover, in the model for skin manifestations, nonbiological systematic treatment (OR = 2.15, 95% CI: 1.08–4.27, and P=0.029) and high BMI (OR = 1.10, 95% CI: 1.00–1.20, and P=0.042) were correlative factors. Conclusions. Our data suggested that differential psoriatic treatment might be a correlative factor in developing symptomatic or asymptomatic Omicron infection and presenting cutaneous signs.
背景。冠状病毒 2019(COVID-19)对全球的影响引起了人们对银屑病患者管理的关注,尤其是使用生物制剂的患者。方法。我们于2023年1月9日至1月22日在四川大学华西医院皮肤科对感染了Omicron病毒(确诊、可能和疑似)的银屑病患者进行了一项基于调查的研究。我们收集了人口统计学和临床信息(银屑病和 COVID-19 相关信息),并进行了统计分析。结果在240名入选患者中,按银屑病治疗方法分为生物制剂治疗(138人)、非生物系统治疗(52人)、局部治疗或无药物治疗(50人)。这项研究显示了患者与奥美康相关的症状和皮肤体征的特点。我们观察到,在完全调整的逻辑模型中,接受局部治疗或未接受药物治疗的患者出现 COVID-19 症状的风险较低(OR = 0.40,95% CI:0.18-0.90,P=0.025)。此外,在皮肤表现模型中,非生物系统治疗(OR = 2.15,95% CI:1.08-4.27,P=0.029)和高体重指数(OR = 1.10,95% CI:1.00-1.20,P=0.042)是相关因素。结论我们的数据表明,不同的银屑病治疗可能是导致无症状或无症状奥米克龙感染并出现皮肤症状的相关因素。
{"title":"The Characteristics of COVID-19 Symptoms and Skin Manifestations among Nonhospitalized COVID-19 Patients with Psoriasis during the Omicron Pandemic in China: A Single-Center Survey-Based Study","authors":"Yue Xiao, Xiwen Zhang, Xun Feng, Jingya Gao, Furong Li, Wenyao Mi, Mingqi Wang, Yuanxia Gu, Yiyi Wang, Wen Wang, W. Li","doi":"10.1155/2023/1559937","DOIUrl":"https://doi.org/10.1155/2023/1559937","url":null,"abstract":"Background. The global impact of coronavirus 2019 (COVID-19) has raised concerns about the management of psoriasis patients, especially among those using biologics. Methods. We conducted a survey-based research among Omicron-infected (confirmed, probable, and suspected ones) psoriasis patients in the department of dermatology, West China Hospital, Sichuan University, from January 9th to January 22nd, 2023. We collected demographic and clinical information (psoriasis- and COVID-19-related) and conducted statistics analysis. Results. Of the 240 patients enrolled, they were classified by the psoriatic treatment, as biologics (n = 138), nonbiological systematic treatment (n = 52), and topical treatment or without pharmacological treatment (n = 50). This study showed the characteristics of Omicron-related symptoms and cutaneous signs in patients. We observed that patients who received topical treatment or without pharmacological treatment had a lower risk of presenting with COVID-19 symptoms in the fully adjusted logistic model (OR = 0.40, 95% CI: 0.18–0.90, and P=0.025). Moreover, in the model for skin manifestations, nonbiological systematic treatment (OR = 2.15, 95% CI: 1.08–4.27, and P=0.029) and high BMI (OR = 1.10, 95% CI: 1.00–1.20, and P=0.042) were correlative factors. Conclusions. Our data suggested that differential psoriatic treatment might be a correlative factor in developing symptomatic or asymptomatic Omicron infection and presenting cutaneous signs.","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"10 5","pages":""},"PeriodicalIF":3.6,"publicationDate":"2023-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139157540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment Resistance to TNF-α Inhibitors in Patients with Psoriasis 银屑病患者对 TNF-α 抑制剂的耐药性
IF 3.6 4区 医学 Q1 DERMATOLOGY Pub Date : 2023-12-21 DOI: 10.1155/2023/7399468
Amirmansoor Gholami, Ahmad Vafaeian, M. Daneshpazhooh, I. Etesami, K. Balighi, Delnavaz Jan, A. Salehi Farid, Ali Vafaei, H. Mahmoudi
Background. Treatment resistance to biologic treatment at specific sites in the body is a challenging issue. However, there is insufficient evidence for factors affecting the resistance of these areas to biological therapies. Methods. In this study, patients with moderate-to-severetreatment-resistant psoriasis who were biologic naïve and referred to Razi hospital were included. The relationship between treatment resistance in different areas and demographic and clinical variables was investigated. Results. A total of 131 biologic-naïve patients with psoriasis treated with anti-TNF-α were included in this study. The most common resistant sites included the scalp, anterior lower legs, and elbows. Also, hand- and toe-nail involvements were considerable. BMI, gender, smoking, PASI score, the duration of the disease, the time distance between diagnosis and treatment, and treatment regiments were found to affect the incidence of resistance to treatment in multiple areas, while age, the incidence of recalcitrant disease and/or psoriatic arthritis, and the duration of current treatment did not have effects. Conclusion. The most common refractory sites were the scalp, anterior lower legs, and elbows. This study should be followed up with larger samples containing a variety of biological treatments in order to evaluate the results.
背景。体内特定部位对生物疗法的耐药性是一个具有挑战性的问题。然而,目前还没有足够的证据表明影响这些部位对生物疗法产生耐药性的因素。研究方法本研究纳入了转诊至拉齐医院的中度至重度耐药银屑病患者,这些患者均对生物制剂治疗持 "天真 "态度。研究了不同部位的耐药性与人口统计学和临床变量之间的关系。研究结果本研究共纳入了131名接受过抗TNF-α治疗、对生物制剂不敏感的银屑病患者。最常见的耐药部位包括头皮、小腿前侧和肘部。此外,手部和脚趾甲的受累情况也相当严重。研究发现,体重指数(BMI)、性别、吸烟、PASI 评分、病程、诊断与治疗之间的时间间隔以及治疗方案会影响多个部位的耐药发生率,而年龄、顽固性疾病和/或银屑病关节炎的发生率以及当前治疗的持续时间则没有影响。结论最常见的难治部位是头皮、小腿前侧和肘部。本研究应采用含有多种生物治疗方法的更大样本进行后续研究,以评估结果。
{"title":"Treatment Resistance to TNF-α Inhibitors in Patients with Psoriasis","authors":"Amirmansoor Gholami, Ahmad Vafaeian, M. Daneshpazhooh, I. Etesami, K. Balighi, Delnavaz Jan, A. Salehi Farid, Ali Vafaei, H. Mahmoudi","doi":"10.1155/2023/7399468","DOIUrl":"https://doi.org/10.1155/2023/7399468","url":null,"abstract":"Background. Treatment resistance to biologic treatment at specific sites in the body is a challenging issue. However, there is insufficient evidence for factors affecting the resistance of these areas to biological therapies. Methods. In this study, patients with moderate-to-severetreatment-resistant psoriasis who were biologic naïve and referred to Razi hospital were included. The relationship between treatment resistance in different areas and demographic and clinical variables was investigated. Results. A total of 131 biologic-naïve patients with psoriasis treated with anti-TNF-α were included in this study. The most common resistant sites included the scalp, anterior lower legs, and elbows. Also, hand- and toe-nail involvements were considerable. BMI, gender, smoking, PASI score, the duration of the disease, the time distance between diagnosis and treatment, and treatment regiments were found to affect the incidence of resistance to treatment in multiple areas, while age, the incidence of recalcitrant disease and/or psoriatic arthritis, and the duration of current treatment did not have effects. Conclusion. The most common refractory sites were the scalp, anterior lower legs, and elbows. This study should be followed up with larger samples containing a variety of biological treatments in order to evaluate the results.","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"42 26","pages":""},"PeriodicalIF":3.6,"publicationDate":"2023-12-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138949977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T-Cell Lymphoma 治疗晚期皮肤 T 细胞淋巴瘤的莫干单抗多模式疗法与全身性类视黄醇、干扰素或体外射光疗法
IF 3.6 4区 医学 Q1 DERMATOLOGY Pub Date : 2023-12-19 DOI: 10.1155/2023/7625926
David M. Weiner, Supriya Rastogi, Daniel J. Lewis, Leah Cohen, Sara Choi, C. Vittorio, P. Haun, Sara S. Samimi, J. Villaseñor‐Park, R. Bhansali, E. Chong, D. Landsburg, S. Nasta, S. J. Schuster, J. Svoboda, Ellen J. Kim, Alain H. Rook, Stefan K. Barta
Mogamulizumab is a novel monoclonal antibody designed to target CC chemokine receptor 4 (CCR4), which is expressed by tumor cells in cutaneous T-cell lymphoma (CTCL). In clinical trials, mogamulizumab monotherapy has demonstrated efficacy in reducing tumor burden in advanced CTCL, particularly in the peripheral blood. In clinical practice at our center, mogamulizumab has been combined with other agents such as systemic interferon, systemic retinoids, and extracorporeal photopheresis for an enhanced synergistic effect. There is limited published research on mogamulizumab combination therapy. This study evaluates the clinical efficacy of mogamulizumab in combination with systemic interferon, retinoids, and/or extracorporeal photopheresis for therapy of CTCL. Nineteen patients on this regimen at our academic center were identified. Treatment response rates, progression-free survival, duration of response, and adverse effects were characterized by retrospective chart review. All patients on this regimen at our center had an initial partial or complete response. Moreover, responses were durable, and the regimen was well-tolerated with few grade 3 adverse effects. These results demonstrate the utility of a multimodality approach to the therapy of CTCL with mogamulizumab and warrant further confirmation.
Mogamulizumab是一种新型单克隆抗体,设计用于靶向皮肤T细胞淋巴瘤(CTCL)中肿瘤细胞表达的CC趋化因子受体4(CCR4)。在临床试验中,mogamulizumab 单药疗法在减轻晚期 CTCL 的肿瘤负荷,尤其是外周血中的肿瘤负荷方面表现出了疗效。在我们中心的临床实践中,mogamulizumab与其他药物(如全身性干扰素、全身性维甲酸和体外射血疗法)联合使用,以增强协同效应。关于莫干珠单抗联合疗法的研究成果有限。本研究评估了mogamulizumab与全身性干扰素、维甲酸和/或体外光化疗法联合治疗CTCL的临床疗效。在我们的学术中心,19 名患者接受了这一治疗方案。通过回顾性病历审查,对治疗反应率、无进展生存期、反应持续时间和不良反应进行了描述。在我们中心使用该疗法的所有患者都获得了初步的部分或完全应答。此外,反应是持久的,而且该方案耐受性良好,很少出现 3 级不良反应。这些结果证明了使用莫干单抗治疗CTCL的多模式方法的实用性,值得进一步证实。
{"title":"Mogamulizumab Multimodality Therapy with Systemic Retinoids, Interferon, or Extracorporeal Photopheresis for Advanced Cutaneous T-Cell Lymphoma","authors":"David M. Weiner, Supriya Rastogi, Daniel J. Lewis, Leah Cohen, Sara Choi, C. Vittorio, P. Haun, Sara S. Samimi, J. Villaseñor‐Park, R. Bhansali, E. Chong, D. Landsburg, S. Nasta, S. J. Schuster, J. Svoboda, Ellen J. Kim, Alain H. Rook, Stefan K. Barta","doi":"10.1155/2023/7625926","DOIUrl":"https://doi.org/10.1155/2023/7625926","url":null,"abstract":"Mogamulizumab is a novel monoclonal antibody designed to target CC chemokine receptor 4 (CCR4), which is expressed by tumor cells in cutaneous T-cell lymphoma (CTCL). In clinical trials, mogamulizumab monotherapy has demonstrated efficacy in reducing tumor burden in advanced CTCL, particularly in the peripheral blood. In clinical practice at our center, mogamulizumab has been combined with other agents such as systemic interferon, systemic retinoids, and extracorporeal photopheresis for an enhanced synergistic effect. There is limited published research on mogamulizumab combination therapy. This study evaluates the clinical efficacy of mogamulizumab in combination with systemic interferon, retinoids, and/or extracorporeal photopheresis for therapy of CTCL. Nineteen patients on this regimen at our academic center were identified. Treatment response rates, progression-free survival, duration of response, and adverse effects were characterized by retrospective chart review. All patients on this regimen at our center had an initial partial or complete response. Moreover, responses were durable, and the regimen was well-tolerated with few grade 3 adverse effects. These results demonstrate the utility of a multimodality approach to the therapy of CTCL with mogamulizumab and warrant further confirmation.","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"113 13","pages":""},"PeriodicalIF":3.6,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138959724","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Gasdermin C (GSDMC) is Overexpressed in Psoriatic Tissue and Elevated in Psoriatic Serum: A Potential Marker of Cell Proliferation and Local Hypoxia in Psoriasis? Gasdermin C (GSDMC) 在银屑病组织中过度表达,并在银屑病血清中升高:银屑病细胞增殖和局部缺氧的潜在标记物?
IF 3.6 4区 医学 Q1 DERMATOLOGY Pub Date : 2023-12-16 DOI: 10.1155/2023/7813287
Julia Nowowiejska, A. Baran, J. Hermanowicz, A. Pryczynicz, B. Sieklucka, Dariusz Pawlak, I. Flisiak
Psoriasis is an important disease in dermatological practice and, despite many studies, its pathogenesis is still not fully understood. Gasdermin C (GSDMC; melanoma-derived leucine zipper-containing extranuclear factor, MLZE) is a member of the gasdermin protein family. The study enrolled 60 patients with active plaque-type psoriasis and 30 volunteers without dermatoses. GSDMC concentration was assessed in serum and urine samples of all participants using ELISA. GSDMC tissue expression was assessed by immunohistochemistry. The GSDMC concentration was significantly higher in serum of patients than in controls ( p < 0.001 ). A urinary GSDMC/creatinine ratio was significantly lower in patients than in controls ( p < 0.05 ). Psoriatic lesions exhibited a significantly higher expression of GSDMC than nonlesional patients’ skin or controls’ skin ( p < 0.001 , p < 0.01 , respectively). There was a positive correlation between the GSDMC serum concentration and the age of patients (R = 0.31, p = 0.015 ) and a negative correlation between GSDMC and RBC (R = −0.37; p = 0.0038 ), HGB (R = −0.26; p = 0.047 ), and urea concentration (R = −0.36; p = 0.04 ). Our study shows the potential involvement of GSDMC in psoriasis. An increased serum GSDMC and a decreased urinary GSDMC/creatinine ratio could be considered noninvasive psoriasis biomarkers, especially of local hypoxia or cell proliferation.
银屑病是皮肤科的一种重要疾病,尽管进行了许多研究,但对其发病机理仍不完全清楚。Gasdermin C(GSDMC;黑色素瘤衍生的含亮氨酸拉链核外因子,MLZE)是gasdermin蛋白家族的成员。这项研究招募了 60 名活动性斑块型银屑病患者和 30 名无皮肤病的志愿者。使用 ELISA 方法评估了所有参与者血清和尿液样本中的 GSDMC 浓度。免疫组化法评估了 GSDMC 在组织中的表达。患者血清中的 GSDMC 浓度明显高于对照组(P < 0.001)。患者尿液中的 GSDMC/肌酐比值明显低于对照组(P < 0.05)。银屑病皮损中 GSDMC 的表达明显高于非皮损患者或对照组(分别为 p < 0.001 和 p < 0.01)。GSDMC 血清浓度与患者年龄呈正相关(R = 0.31,p = 0.015),与 RBC(R = -0.37;p = 0.0038)、HGB(R = -0.26;p = 0.047)和尿素浓度(R = -0.36;p = 0.04)呈负相关。我们的研究表明,GSDMC 可能与银屑病有关。血清中 GSDMC 的增加和尿液中 GSDMC/肌酐比值的降低可被视为非侵入性银屑病生物标志物,尤其是局部缺氧或细胞增殖的生物标志物。
{"title":"Gasdermin C (GSDMC) is Overexpressed in Psoriatic Tissue and Elevated in Psoriatic Serum: A Potential Marker of Cell Proliferation and Local Hypoxia in Psoriasis?","authors":"Julia Nowowiejska, A. Baran, J. Hermanowicz, A. Pryczynicz, B. Sieklucka, Dariusz Pawlak, I. Flisiak","doi":"10.1155/2023/7813287","DOIUrl":"https://doi.org/10.1155/2023/7813287","url":null,"abstract":"Psoriasis is an important disease in dermatological practice and, despite many studies, its pathogenesis is still not fully understood. Gasdermin C (GSDMC; melanoma-derived leucine zipper-containing extranuclear factor, MLZE) is a member of the gasdermin protein family. The study enrolled 60 patients with active plaque-type psoriasis and 30 volunteers without dermatoses. GSDMC concentration was assessed in serum and urine samples of all participants using ELISA. GSDMC tissue expression was assessed by immunohistochemistry. The GSDMC concentration was significantly higher in serum of patients than in controls (\u0000 \u0000 p\u0000 <\u0000 0.001\u0000 \u0000 ). A urinary GSDMC/creatinine ratio was significantly lower in patients than in controls (\u0000 \u0000 p\u0000 <\u0000 0.05\u0000 \u0000 ). Psoriatic lesions exhibited a significantly higher expression of GSDMC than nonlesional patients’ skin or controls’ skin (\u0000 \u0000 p\u0000 <\u0000 0.001\u0000 \u0000 , \u0000 \u0000 p\u0000 <\u0000 0.01\u0000 \u0000 , respectively). There was a positive correlation between the GSDMC serum concentration and the age of patients (R = 0.31, \u0000 \u0000 p\u0000 =\u0000 0.015\u0000 \u0000 ) and a negative correlation between GSDMC and RBC (R = −0.37; \u0000 \u0000 p\u0000 =\u0000 0.0038\u0000 \u0000 ), HGB (R = −0.26; \u0000 \u0000 p\u0000 =\u0000 0.047\u0000 \u0000 ), and urea concentration (R = −0.36; \u0000 \u0000 p\u0000 =\u0000 0.04\u0000 \u0000 ). Our study shows the potential involvement of GSDMC in psoriasis. An increased serum GSDMC and a decreased urinary GSDMC/creatinine ratio could be considered noninvasive psoriasis biomarkers, especially of local hypoxia or cell proliferation.","PeriodicalId":11045,"journal":{"name":"Dermatologic Therapy","volume":"23 1","pages":""},"PeriodicalIF":3.6,"publicationDate":"2023-12-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138966860","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Dermatologic Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1